Important germline mutations related to breast and ovarian cancer such as BRCA1 and BRCA2 (BRCA1/2) have been identified [4], and other high- and moderate-risk genes have been found to be associated with increased risk for these cancers [5]. The gene discussed is BRCA2; the disease is cancer.